Friday, May 14, 2021

Minsa lanza advertencia por uso de dióxido de cloro como tratamiento para la Covid-19

Minsa issues a warning for the use of chlorine dioxide as a treatment for Covid-19

The Department of Pharmacy and Drugs of the Ministry of Health (Minsa) reported this Tuesday, February 2, that it has received reports of people who "experience adverse events" after taking a product that contains chlorine dioxide as a treatment against Covid-19.
These events include respiratory failure, changes in the electrical activity of the heart, abnormal heart rhythms, low blood pressure caused by dehydration, acute liver failure, low blood cell counts, severe vomiting, and severe diarrhea.

"Currently, there are no clinical studies to support the efficacy and safety of chlorine dioxide for the treatment of Covid-19," the health authorities indicated.

In these cases, the Minsa asked the population not to eat products whose content contains chlorine dioxide or are being sold as "miraculous cures".

"The main drug regulatory authorities worldwide are warning about possible health complications that the use of these products could have," the ministry said in a statement.

Related Articles